Altimmune Income Statement (2010-2025) | ALT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.84M	0.14M	0.16M	3.28M	0.03M	0.01M	0.00M	0.03M	0.02M	0.01M	0.36M	0.04M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.03M
Operating items
Depreciation & Amortization - Total (Quarter)
Research & Development (Quarter)	11.88M	13.27M	29.21M	20.18M	15.10M	15.99M	20.26M	19.18M	17.25M	13.25M	18.39M	16.91M	21.49M	21.16M	19.80M	19.78M	15.83M	17.24M	14.96M	18.41M
Selling, General & Administrative (Quarter)	3.82M	3.66M	4.16M	3.78M	4.43M	4.41M	4.49M	3.81M	4.53M	4.76M	4.51M	4.33M	5.31M	5.59M	4.97M	5.09M	5.99M	5.69M	5.90M	10.51M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)		8.07M		3.30M								12.42M
Operating Expenses (Quarter)	15.70M	25.00M	33.36M	27.26M	19.53M	20.40M	24.75M	22.98M	21.78M	18.01M	22.90M	33.66M	26.80M	26.75M	24.77M	24.87M	21.82M	22.93M	20.86M	28.92M
Operating Income (Quarter)	-14.86M	-24.86M	-33.20M	-23.98M	-19.50M	-20.39M	-24.75M	-23.09M	-21.76M	-18.01M	-22.54M	-33.62M	-26.79M	-26.75M	-24.77M	58.34M	-21.82M	-22.92M	-20.86M	46.95M
EBIT (Quarter)	-14.86M	-24.86M	-33.20M	-23.98M	-19.50M	-20.39M	-24.75M	-23.09M	-21.76M	-18.01M	-22.54M	-33.62M	-26.79M	-26.75M	-24.77M	58.34M	-21.82M	-22.92M	-20.86M	46.95M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	0.04M	0.03M	0.01M	0.12M	0.02M	0.33M	1.05M	1.47M	1.67M	1.83M	1.88M	1.96M	2.41M	2.18M	1.91M	1.57M	1.54M	1.13M	2.43M	2.44M
Other Non Operating Income (Quarter)	-0.03M	0.03M	-0.29M	-0.08M	0.11M	0.03M	0.05M	-0.22M	0.02M	0.11M	0.01M	0.02M	-0.01M	-0.08M	0.02M	0.12M	0.01M	-0.09M	-0.09M	-0.03M
Non Operating Income (Quarter)	-0.03M	0.04M	-0.31M	-0.10M	0.11M	0.03M	1.04M	-0.22M	1.69M	1.95M	1.87M	0.02M	-0.01M	-0.08M	0.02M	1.69M	0.01M	0.78M	-0.09M	-0.03M
Net income details
EBT (Quarter)	-14.86M	-24.83M	-33.51M	54.69M	-19.54M	-20.13M	-23.71M	-21.66M	-20.09M	-16.17M	-20.67M	34.06M	-24.39M	-24.64M	-22.84M	65.22M	-20.26M	-22.15M	-19.01M	57.89M
Tax Provisions (Quarter)							-0.20M	0.05M									-0.68M
Profit After Tax (Quarter)	-14.86M	-24.83M	-33.51M	-23.89M	-19.43M	-20.11M	-23.52M	-21.66M	-20.07M	-16.06M	-20.67M	-31.64M	-24.39M	-24.64M	-22.84M	-23.18M	-19.57M	-22.15M	-19.01M	-27.36M
Net Income - Minority (Quarter)
Income from Continuing Operations (Quarter)	-14.86M	-24.83M	-33.51M	54.69M	-19.54M	-20.13M	-23.51M	-21.71M	-20.09M	-16.17M	-20.67M	34.06M	-24.39M	-24.64M	-22.84M	65.22M	-19.57M	-22.15M	-19.01M	57.89M
Consolidated Net Income (Quarter)	-14.86M	-24.83M	-33.51M	54.69M	-19.54M	-20.13M	-23.51M	-21.71M	-20.09M	-16.17M	-20.67M	34.06M	-24.39M	-24.64M	-22.84M	65.22M	-19.57M	-22.15M	-19.01M	57.89M
Income towards Parent Company (Quarter)	-14.86M	-24.83M	-33.51M	54.69M	-19.54M	-20.13M	-23.51M	-21.71M	-20.09M	-16.17M	-20.67M	34.06M	-24.39M	-24.64M	-22.84M	65.22M	-19.57M	-22.15M	-19.01M	57.89M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-14.86M	-24.83M	-33.51M	54.69M	-19.54M	-20.13M	-23.51M	-21.71M	-20.09M	-16.17M	-20.67M	34.06M	-24.39M	-24.64M	-22.84M	65.22M	-19.57M	-22.15M	-19.01M	57.89M
Additional items
EPS (Basic) (Quarter)	-0.38	-0.60	-0.81	-0.56	-0.44	-0.42	-0.48	-0.44	-0.40	-0.32	-0.39	-0.56	-0.34	-0.35	-0.32	-0.33	-0.26	-0.27	-0.21	-0.26
EPS (Weighted Average and Diluted) (Quarter)	-0.38	-0.60	-0.81	-0.56	-0.44	-0.42	-0.48	-0.44	-0.40	-0.32	-0.39	-0.56	-0.34	-0.35	-0.32	-0.33	-0.26	-0.27	-0.21	-0.26
Shares Outstanding (Weighted Average) (Quarter)	2.78M	2.78M	2.78M	2.78M	43.97M	1.02M	1.02M	46.93M	50.13M	50.69M	53.63M	53.25M		70.92M		71.00M	75.55M	81.48M	82.20M	88.10M
Shares Outstanding (Diluted Average) (Quarter)	38.91M	41.36M	40.84M	41.28M	43.97M	44.15M	49.29M	46.93M	50.13M	50.69M	53.63M	53.25M	70.80M	70.86M	71.08M	71.00M	75.55M	81.48M	82.20M	88.10M
EBITDA (Quarter)	-14.86M	-24.83M	-33.51M	-23.89M	-19.43M	-20.23M	-23.66M	-21.58M	-19.95M	-16.14M	-20.61M	-31.52M	-24.55M	-24.67M	-22.50M	-23.31M	-19.61M	-22.18M	-18.99M	-27.27M
Interest Expenses (Quarter)	0.01M	0.02M	0.03M	-0.06M	0.06M	0.07M	0.06M	-0.18M	0.00M	0.00M	0.03M	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M	0.26M	0.49M	0.88M
Shares Outstanding (Quarter)	38.26M	39.69M	39.70M	40.99M	43.22M	46.37M	49.16M	49.20M	49.29M	52.66M	52.86M	70.68M	70.90M	71.05M	71.12M	72.35M	77.83M	85.08M	95.60M	110.88M
Tax Rate (Quarter)							0.84	-0.24									3.36

Research Tools

Altimmune Income Statement (2010-2025) | ALT

Create an account

Sign In

Reset Password